Fennec Pharmaceuticals (FENC) to Release Quarterly Earnings on Thursday

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Fennec Pharmaceuticals (NASDAQ:FENC – […]

Related Keywords

United States ,America ,Chrisa Rallis ,Robert Andrade ,Earnings History For Fennec Pharmaceuticals ,Fennec Pharmaceuticals Price Performance ,Cantor Fitzgerald ,Securities Exchange Commission ,Institutional Trading Of Fennec Pharmaceuticals ,News Ratings For Fennec Pharmaceuticals Daily ,Fennec Pharmaceuticals ,Boothbay Fund Management ,Fennec Pharmaceuticals Inc ,Barclays Plc ,Nasdaq ,Jpmorgan Chase Co ,America Corp ,Get Free Report ,Exchange Commission ,Director Chris ,Fund Management ,Pharmaceuticals Inc ,Sodium Thiosulfate ,Fennec Pharmaceuticals Daily ,Nasdaq Fenc ,Pufenc ,Medical ,Earnings ,